1999
Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia
Jillella A, Doria R, Khan K, Zelterman D, Ahmad Y, Smith B, Holmes W, Becker P, Roberts K, Rappeport J. Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia. Bone Marrow Transplantation 1999, 23: 1095-1100. PMID: 10382947, DOI: 10.1038/sj.bmt.1701786.Peer-Reviewed Original ResearchConceptsAllogeneic bone marrow transplantationTotal body irradiationBone marrow transplantationConditioning regimenMarrow transplantationMyeloablative regimenRelapse rateBody irradiationHematologic malignanciesAntileukemic effectGood prognosis diseaseHigh-dose cytosineHost disease (GVHD) prophylaxisShort-course methotrexateEvidence of diseaseOverall relapse rateHigh-dose AraPoor prognosis diseaseKaplan-Meier estimatesActuarial survivalConditioning regimensDisease prophylaxisMyeloablative regimensProspective studyRegimen
1985
Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria: eradication of the PNH clone and documentation of complete lymphohematopoietic engraftment.
Antin JH, Ginsburg D, Smith BR, Nathan DG, Orkin SH, Rappeport JM. Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria: eradication of the PNH clone and documentation of complete lymphohematopoietic engraftment. Blood 1985, 66: 1247-50. PMID: 3904867, DOI: 10.1182/blood.v66.6.1247.bloodjournal6661247.Peer-Reviewed Original ResearchConceptsParoxysmal nocturnal hemoglobinuriaBone marrow transplantationConditioning regimenMarrow transplantationMarrow aplasiaPNH cloneNocturnal hemoglobinuriaPretransplant conditioning regimenCurative therapyAntithymocyte serumComplete engraftmentMarrow graftingSuccessful treatmentAbnormal clonePatientsHematopoietic stem cellsRBC typingTransplantationRegimenCell linesAplasiaDNA sequence polymorphism analysisEngraftmentHemoglobinuriaStem cellsBone Marrow Transplantation for Paroxysmal Nocturnal Hemoglobinuria: Eradication of the PNH Clone and Documentation of Complete Lymphohematopoietic Engraftment
Antin J, Ginsburg D, Smith B, Nathan D, Orkin S, Rappeport J. Bone Marrow Transplantation for Paroxysmal Nocturnal Hemoglobinuria: Eradication of the PNH Clone and Documentation of Complete Lymphohematopoietic Engraftment. Blood 1985, 66: 1247-1250. DOI: 10.1182/blood.v66.6.1247.1247.Peer-Reviewed Original ResearchParoxysmal nocturnal hemoglobinuriaBone marrow transplantationConditioning regimenMarrow transplantationMarrow aplasiaPNH cloneNocturnal hemoglobinuriaPretransplant conditioning regimenCurative therapyAntithymocyte serumComplete engraftmentMarrow graftingSuccessful treatmentAbnormal clonePatientsHematopoietic stem cellsRBC typingTransplantationRegimenCell linesAplasiaDNA sequence polymorphism analysisEngraftmentHemoglobinuriaStem cellsEFFICACY OF A CYCLOPHOSPHAMIDE-PROCARBAZINE-ANTITHYMOCYTE SERUM REGIMEN FOR PREVENTION OF GRAFT REJECTION FOLLOWING BONE MARROW TRANSPLANTATION FOR TRANSFUSED PATIENTS WITH APLASTIC ANEMIA
Smith BR, Guinan EC, Parkman R, Ferrara J, Levey RH, Nathan DG, Rappeport JM. EFFICACY OF A CYCLOPHOSPHAMIDE-PROCARBAZINE-ANTITHYMOCYTE SERUM REGIMEN FOR PREVENTION OF GRAFT REJECTION FOLLOWING BONE MARROW TRANSPLANTATION FOR TRANSFUSED PATIENTS WITH APLASTIC ANEMIA. Transplantation 1985, 39: 671-672. PMID: 3890295, DOI: 10.1097/00007890-198506000-00020.Peer-Reviewed Original Research
1984
Busulfan and Total Body Irradiation as Antihematopoietic Stem Cell Agents in the Preparation of Patients With Congenital Bone Marrow Disorders for Allogeneic Bone Marrow Transplantation
Parkman R, Rappeport J, Hellman S, Lipton J, Smith B, Geha R, Nathan D. Busulfan and Total Body Irradiation as Antihematopoietic Stem Cell Agents in the Preparation of Patients With Congenital Bone Marrow Disorders for Allogeneic Bone Marrow Transplantation. Blood 1984, 64: 852-857. DOI: 10.1182/blood.v64.4.852.852.Peer-Reviewed Original ResearchTotal body irradiationBone marrow transplantationBone marrow disordersAllogeneic bone marrow transplantationBody irradiationPreparation of patientsMarrow transplantationMarrow disordersInterstitial pneumonitisIdiopathic interstitial pneumonitisCell agentsPreparatory regimenBusulfanPatientsHematopoietic stem cellsTransplantationTransplantPneumonitisDisordersHematopoietic ablationStem cellsRegimenRegimensAgentsBusulfan and total body irradiation as antihematopoietic stem cell agents in the preparation of patients with congenital bone marrow disorders for allogenic bone marrow transplantation.
Parkman R, Rappeport JM, Hellman S, Lipton J, Smith B, Geha R, Nathan DG. Busulfan and total body irradiation as antihematopoietic stem cell agents in the preparation of patients with congenital bone marrow disorders for allogenic bone marrow transplantation. Blood 1984, 64: 852-7. PMID: 6383499, DOI: 10.1182/blood.v64.4.852.bloodjournal644852.Peer-Reviewed Original ResearchConceptsTotal body irradiationBone marrow transplantationBone marrow disordersBody irradiationPreparation of patientsMarrow transplantationMarrow disordersInterstitial pneumonitisAllogeneic bone marrow transplantationAllogenic bone marrow transplantationIdiopathic interstitial pneumonitisCell agentsPreparatory regimenBusulfanPatientsHematopoietic stem cellsTransplantationTransplantPneumonitisDisordersHematopoietic ablationStem cellsRegimenRegimensAgents